OpenAlex
PricingAboutJobs
Log inGet started
Work

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

HTML

Year: 2014
Type: article
Source: Nature
DOI: 10.1038/nature13444
Authors: Khaled Ali, Dalya R. Soond, Roberto Piñeiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L. Scudamore, Timothy Hancox, Heather Maecker, Lori Friedman, Martin Turner, Klaus Okkenhaug, Bart Vanhaesebroeck
Institutions: University College London, Babraham Institute, Queen Mary University of London, Barts Cancer Institute, Royal Veterinary College, Genentech
Language: English

Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: PI3K p110δ, regulatory T cells, immunosuppression, CD8+ cytotoxic T lymphocytes, tumor growth, metastasis, PI3K inhibitors, cancer immunotherapy, solid tumors
SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, Cancer Research UK, Genentech, Biotechnology and Biological Sciences Research Council
Awards: Immune responses to the environment, G1262478387, G1792706451, PI3K signalling in Immunity and Infection., G3348624206, G3383090962, G3593120002, G394650441, PI3K signalling in regulatory T cells., G5099126385, G6355942424, G6363520850, G6471408994, G8200864203, G8785548394
OpenAlex ID: W1980040544
FWCI: 17.58
Cites: 23
Cited by: 584
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security